Ozempic Cost in Canada: Price, Insurance & Ways to Save (2026)

What Ozempic Costs in Canada Right Now

Brand-name Ozempic runs roughly $250 to $310 per month at Canadian pharmacies in 2026 without coverage. The bigger change this year is generic semaglutide: Health Canada authorized the first in April 2026 and a second in May, and pharmacies now list it from about $88 to $150 a month — $88.88 at Costco, $99.00 at Rexall and $103.53 at Shoppers Drug Mart in reported comparisons. Since May 29, 2026, Novo Nordisk's savings card has also brought brand Ozempic broadly into line with generic pricing for people without drug coverage. Those figures are the going rate, not a quote: your dose, dispensing fee, province and plan all move the final number, so ask two or three licensed pharmacies for an all-in total before you commit.

• Brand Ozempic: about $250-$310 per month without coverage.
• Generic semaglutide: from about $88 per month, stocked at major chains.
• Manufacturer savings card: narrows the brand-versus-generic gap for uninsured patients.
• Assessment is separate: TelePlus Care charges $149 for the medical assessment, $99 monthly after, or $499 for six months. In Alberta, the visits are covered by Alberta Health when your family doctor or nurse practitioner refers you to Dr. Jerudi.

Ozempic vs. Wegovy: Why the Approved Use Drives Your Cost

This distinction matters for your wallet. Ozempic (semaglutide) is Health Canada-authorized to treat type 2 diabetes; its Notice of Compliance dates to January 2018. It is not approved as a weight-loss drug. Wegovy, a higher-dose semaglutide from the same manufacturer, is the version Health Canada authorized for chronic weight management (authorized in 2021, and available in Canada from 2024). Because drug-plan coverage generally follows the approved indication, plans typically pay for Ozempic when it treats diabetes and decline it when it is prescribed off-label for weight loss. Canadian clinical guidance from Diabetes Canada also supports GLP-1 receptor agonists for many people with type 2 diabetes, particularly those at higher cardiovascular or kidney risk. A licensed prescriber must assess whether any semaglutide product is appropriate for you; a prescription is never guaranteed, and this article is not medical advice.

Provincial Drug Plans: Diabetes Yes, Weight Loss Almost Never

Every province and territory runs its own public drug plan, and the pattern is consistent: semaglutide is generally covered for type 2 diabetes under clinical criteria, and generally not covered for weight loss or obesity. Coverage usually requires a special-authority or limited-use request that your prescriber submits, often documenting that a first-line therapy such as metformin has not achieved adequate blood-sugar control. In Ontario, for example, Ozempic moved to a Limited Use category under the Ontario Drug Benefit (ODB) in 2024, requiring a diabetes-specific code. Public plans also differ in who they cover, from seniors and social-assistance recipients to income-based programs such as Ontario's Trillium Drug Program. Because rules and criteria change over time, confirm the current terms with your provincial plan and pharmacist rather than relying on any online summary, including this one.

• Coverage is generally for type 2 diabetes, not weight loss or prediabetes.
• Expect a special-authority or limited-use request submitted by your prescriber.
• Eligibility (age, income, program enrolment) varies province to province.
• Income-based programs may cap what a household pays out of pocket each year.

Private and Employer Insurance: Prior Authorization Is the Key

If you have a private or employer benefits plan, semaglutide for type 2 diabetes is often eligible, but frequently requires prior authorization. That means your insurer reviews clinical documentation, such as a confirmed diagnosis, recent HbA1c results, and evidence that earlier treatments were tried, before approving reimbursement. Weight-loss coverage is far less common: some plans exclude anti-obesity medications entirely, while others offer optional weight-management riders with their own BMI thresholds, prior-authorization steps, and step-therapy rules. Plan designs vary enormously between employers, so the only reliable way to know what you are entitled to is to read your plan booklet or call your insurer directly and ask about semaglutide by name. If you are switching jobs or plans, check whether an existing prior authorization carries over or has to be resubmitted, since a gap can mean paying full price temporarily.

• Ask whether semaglutide is on your plan's formulary, and for which indication.
• Confirm whether prior authorization is required, and exactly what documentation.
• Check for a separate weight-management rider and its specific rules.
• Ask about your co-pay, deductible, and any annual maximum.

Generic Semaglutide and the 2026 Price Shift

A significant change arrived in 2026: Health Canada authorized generic versions of semaglutide, and Canada became the first G7 country to do so. Keep in mind that approved indications, pharmacy stock, and how insurers handle the generic can differ from the brand. If cost is a concern, ask your prescriber whether an authorized generic semaglutide is clinically appropriate for you, and ask your pharmacist which authorized products they stock and at what all-in price. Do not switch products or change your dose on your own; any change should go through your prescriber and pharmacist.

Legitimate Ways to Lower Your Ozempic Cost

Beyond insurance, several legitimate strategies can lower what you pay, none of which involve compromising on safety or buying from unauthorized sellers. Start with coverage, because it usually dwarfs every other saving: if you have type 2 diabetes, getting a special-authority or prior-authorization request approved can move you from full price to a modest co-pay. From there, small operational choices add up. Dispensing fees vary from pharmacy to pharmacy, so the same pen can cost noticeably more at one counter than another, and a longer supply means fewer dispensing fees over a year. The arrival of authorized generic semaglutide in 2026 adds another lever. Always weigh these against clinical advice: never stretch, split, or skip doses to save money, and never substitute an unauthorized product. Ask your pharmacist to walk through the options, since pharmacists are an underused and free source of cost advice.

• Confirm coverage first: have your prescriber submit any special-authority or prior-authorization request; approval for diabetes can eliminate most of the cost.
• Compare pharmacies: dispensing fees differ, and in Canada you can use a warehouse pharmacy, such as a Costco pharmacy, without a membership.
• Ask about a 90-day supply, if clinically appropriate, to reduce total dispensing fees over the year.
• Consider authorized generic semaglutide if your prescriber agrees it fits your situation.
• Check manufacturer patient-support or co-pay-assistance programs; eligibility and amounts vary, so confirm the official terms.
• Explore income-based public programs (for example, Ontario's Trillium Drug Program) if drug costs are high relative to income.
• Claim eligible medication costs under the federal medical-expense tax credit.

Avoid the False Economy of Counterfeit Semaglutide

The most expensive mistake is buying cheap semaglutide from the wrong place. Health Canada has warned Canadians not to buy or use fake or unauthorized versions of GLP-1 drugs, which have turned up at some retailers and on websites and social media. Counterfeit or unauthorized products may contain the wrong dose, no active ingredient at all, or contaminants, and can cause serious harm. Health Canada has also stated that unauthorized compounding of semaglutide-containing products is not permitted. Protect yourself by buying only from a licensed pharmacy, insisting on a genuine prescription after a real clinical assessment, and verifying the product's eight-digit Drug Identification Number (DIN) in Health Canada's Drug Product Database. If a price or a no-prescription-needed offer looks too good to be true, it is. When in doubt, ask a pharmacist to confirm a product is authorized before you use it.